特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
952506

世界の血液市場:将来予測 (2019~2028年)

Global Blood Market Forecast 2019-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 189 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円
世界の血液市場:将来予測 (2019~2028年)
出版日: 2020年08月03日
発行: Inkwood Research
ページ情報: 英文 189 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液市場は、2019~2028年に4.16%のCAGRで成長すると推定されています。市場の成長を後押しする主な促進要因には、血液・血液関連製品の世界的な需要拡大や、人口高齢化の進展、血液・血漿の献血量の増加、輸血・血液スクリーニング装置の開発、血液スクリーニングに関する政府規制の整備などが挙げられます。特にアジア太平洋地域では、慢性疾患や院内感染の患者増加に伴い、採血装置などを中心に巨大な市場機会が生じつつあります。

当レポートでは、世界の血液市場 - 各種の血液検査・治療・処理の市場 - について分析し、市場の基本構造や主な促進・抑制要因、市場規模の動向見通し (過去3年間・今後9年間分)、製品別・エンドユーザー別および地域別の詳細動向、市場競争動向、主要企業のプロファイル (企業概要、主要製品/サービス、事業戦略ほか) などについて調査しております。

第1章 調査範囲・手法

第2章 エグゼクティブサマリー

第3章 市場のダイナミクス

  • 母体市場の分析:ソフトウェア市場
  • 市場の定義
  • 主な市場促進要因
    • 世界の血液およびその他の血液関連製品に対する需要の増加
    • 老年人口の地球規模での急増
    • 献血と血漿寄付の増加
    • 血液検査のための政府規制の約束
    • 輸血および血液スクリーニング器具の進歩
  • 主な市場抑制要因
    • 高度な血液採取装置の高コスト
    • 熟練した実験室の専門家の深さ

第4章 主要な分析

  • 主要な投資の考察
  • ポーターのファイブフォース分析
  • 市場機会マトリックス
  • ベンダー情勢
  • 新型コロナウイルス感染症 (COVID-19) の影響 - 血液市場

第5章 製品別の市場

  • 全血採血
    • 全血採血装置
    • 全血採血用試薬
  • 原料血漿採取
    • 原料血漿採取装置
    • 原料血漿採取用試薬
  • 血液治療
    • 静脈内免疫グロブリン(IVIG)
    • アルブミン
    • 過免疫
    • 第VIII因子
    • 第IX因子
    • その他の血液治療
  • 血液型判定
    • 血液型判定装置
    • 血液型判定用試薬
  • 血液スクリーニング
    • 血液スクリーニング装置
    • 血液スクリーニング用試薬
  • 血液処理
    • 血液処理装置
    • 血液処理用試薬

第6章 エンドユーザー別市場

  • 血液バンク/血液成分バンク
  • 診断検査室
  • 外来手術センター
  • 病院
  • その他のエンドユーザー

第7章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • ロシア
    • ベルギー
    • ポーランド
    • 他の欧州諸国
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • インドネシア
    • タイ
    • ベトナム
    • オーストラリア・ニュージーランド
    • 他のアジア太平洋地域諸国
  • 他の国々 (RoW)
    • ラテンアメリカ
    • 中東・アフリカ

第8章 企業プロファイル

  • ABBOTT LABORATORIES
  • BIO-RAD LABORATORIES INC
  • CSL LIMITED (CSL BEHRING)
  • F HOFFMANN-LA ROCHE LTD
  • GRIFOLS INTERNATIONAL SA
  • HAEMONETICS CORPORATION
  • MERCK & CO INC
  • NOVO NORDISK A/S
  • BAXTER INTERNATIONAL INC
  • BECTON DICKINSON AND COMPANY
  • FRESENIUS KABI AG
  • ORTHO CLINICAL DIAGNOSTICS
  • テルモ (TERUMO BCT INC)
  • IMMUCOR INC
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BLOOD
  • TABLE 2: GLOBAL BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL WHOLE BLOOD COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL SOURCE PLASMA COLLECTION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL SOURCE PLASMA COLLECTION SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL SOURCE PLASMA COLLECTION REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL INTRAVENOUS IMMUNOGLOBULIN (IVIG) MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ALBUMIN MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL ALBUMIN SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL HYPERIMMUNE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL HYPERIMMUNE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL FACTOR VIII MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL FACTOR VIII MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL FACTOR IX MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL FACTOR IX MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL OTHER BLOOD THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL BLOOD TYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL BLOOD TYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLI

ON)

  • TABLE 32: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL BLOOD TYPING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL BLOOD TYPING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL BLOOD SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL BLOOD SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL BLOOD SCREENING SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL BLOOD SCREENING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL BLOOD PROCESSING EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL BLOOD MARKET, BY END-USERS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL BLOOD MARKET, BY END-USERS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL BLOOD & BLOOD COMPONENT BANKS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL DIAGNOSTIC LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL BLOOD MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: GLOBAL BLOOD MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 62: NORTH AMERICA BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: NORTH AMERICA BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 64: EUROPE BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 65: EUROPE BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 66: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 67: ASIA PACIFIC BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 68: REST OF WORLD BLOOD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 69: REST OF WORLD BLOOD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY WHOLE BLOOD COLLECTION, IN 2019
  • FIGURE 8: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL BLOOD MARKET, BY WHOLE BLOOD COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY SOURCE PLASMA COLLECTION, IN 2019
  • FIGURE 12: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL BLOOD MARKET, BY BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD THERAPEUTICS, IN 2019
  • FIGURE 16: GLOBAL BLOOD MARKET, BY SOURCE PLASMA COLLECTION SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL BLOOD MARKET, BY ALBUMIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL BLOOD MARKET, BY HYPERIMMUNE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL BLOOD MARKET, BY FACTOR VIII, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL BLOOD MARKET, BY FACTOR IX, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL BLOOD MARKET, BY OTHER BLOOD THERAPEUTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL BLOOD MARKET, BY BLOOD TYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD TYPING, IN 2019
  • FIGURE 24: GLOBAL BLOOD MARKET, BY BLOOD TYPING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL BLOOD MARKET, BY BLOOD TYPING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL BLOOD MARKET, BY BLOOD SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD SCREENING, IN 2019
  • FIGURE 28: GLOBAL BLOOD MARKET, BY BLOOD SCREENING SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL BLOOD MARKET, BY BLOOD SCREENING REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY BLOOD PROCESSING EQUIPMENT, IN 2019
  • FIGURE 32: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT SYSTEMS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL BLOOD MARKET, BY BLOOD PROCESSING EQUIPMENT REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL BLOOD MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 35: GLOBAL BLOOD MARKET, BY BLOOD & BLOOD COMPONENT BANKS, 2019-2028 (IN $ MILLION)
  • FIGURE 36: GLOBAL BLOOD MARKET, BY DIAGNOSTIC LABORATORIES, 2019-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL BLOOD MARKET, BY AMBULATORY SURGICAL CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL BLOOD MARKET, BY HOSPITALS, 2019-2028 (IN $ MILLION)
  • FIGURE 39: GLOBAL BLOOD MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: NORTH AMERICA BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: UNITED STATES BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: CANADA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: EUROPE BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 44: UNITED KINGDOM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: GERMANY BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: FRANCE BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: ITALY BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: RUSSIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: BELGIUM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: POLAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 51: REST OF EUROPE BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: ASIA PACIFIC BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 53: CHINA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 54: JAPAN BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 55: INDIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 56: SOUTH KOREA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 57: INDONESIA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 58: THAILAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 59: VIETNAM BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 60: AUSTRALIA & NEW ZEALAND BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 61: REST OF ASIA PACIFIC BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 62: REST OF WORLD BLOOD MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 63: LATIN AMERICA BLOOD MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 64: MIDDLE EAST & AFRICA BLOOD MARKET, 2019-2028 (IN $ MILLION)
目次
Product Code: 32924

KEY FINDINGS

The global blood market is estimated to grow with a CAGR of 4.16% across the forecast years of 2019 to 2028. Primary factors attributed to driving the market growth include, the increase in the worldwide demand for blood and blood-related products, the growing geriatric population, rise in blood and plasma donations, developments in blood transfusion and screening instruments, and the introduction of government regulations for blood screening.

MARKET INSIGHTS

The global blood market entails the sale of whole blood as well as blood components using diverse mediums like, hospitals, and blood banks, among others. Blood transfusion is typically performed in medical facilities during disease treatments and surgeries, and involves the red blood cells' transfer from one person to another. The donor's blood is collected and then categorized in terms of requirements and components. Since the transfusion process only requires blood components, an entire unit of blood is seldom used.

In recent years, there has been a rapid increase in the geriatric population across the world. Consequently, they are more susceptible to numerous chronic conditions like cardiovascular diseases, type 2 diabetes, arthritis, and obesity. The elderly are also prone to distinct types of cancers like prostate and stomach cancer. Thus, the predisposition to various medical complications, leads to the need for blood and source plasma treatments. As a result, the rise in geriatric populace is expected to raise the demand for blood and plasma collecting reagents and instruments and bolster the market growth.

REGIONAL INSIGHTS

The geographical analysis of the global blood market growth includes the Asia Pacific, North America, Europe, and the rest of the world. Developing economies in the Asia Pacific blood market is witnessing an increasing number of patients suffering from chronic ailments and developments within healthcare institutions. As a result, the region offers profitable opportunities for key market players, especially in the blood collection equipment division.

COMPETITIVE ANALYSIS

The industrial rivalry within the global blood market is estimated to be high across the forecast period. The intense competition is attributed to the rise in healthcare expenses, and the increased prevalence of chronic diseases that require a blood transfusion. Some of the renowned companies in the market include, Bio-Rad Laboratories Inc, Immucor Inc, Abbott Laboratories, CSL Limited, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING DEMAND FOR BLOOD AND OTHER BLOOD RELATED PRODUCTS ACROSS THE WORLD
    • 3.2.2. SURGE IN GERIATRIC POPULATION ACROSS THE GLOBE
    • 3.2.3. RISE IN BLOOD DONATIONS AND PLASMA DONATIONS
    • 3.2.4. PROMISING GOVERNMENT REGULATIONS FOR BLOOD SCREENING
    • 3.2.5. PROGRESSION IN BLOOD TRANSFUSION AND BLOOD SCREENING INSTRUMENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HIGH COST OF ADVANCED BLOOD COLLECTION DEVICES
    • 3.3.2. DEARTH OF SKILLED LABORATORY PROFESSIONALS

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. IMPACT OF COVID - BLOOD MARKET

5. MARKET BY PRODUCT

  • 5.1. WHOLE BLOOD COLLECTION
    • 5.1.1. WHOLE BLOOD COLLECTION SYSTEMS
    • 5.1.2. WHOLE BLOOD COLLECTION REAGENTS
  • 5.2. SOURCE PLASMA COLLECTION
    • 5.2.1. SOURCE PLASMA COLLECTION SYSTEMS
    • 5.2.2. SOURCE PLASMA COLLECTION REAGENTS
  • 5.3. BLOOD THERAPEUTICS
    • 5.3.1. INTRAVENOUS IMMUNOGLOBULIN (IVIG)
    • 5.3.2. ALBUMIN
    • 5.3.3. HYPERIMMUNE
    • 5.3.4. FACTOR VIII
    • 5.3.5. FACTOR IX
    • 5.3.6. OTHER BLOOD THERAPEUTICS
  • 5.4. BLOOD TYPING
    • 5.4.1. BLOOD TYPING SYSTEMS
    • 5.4.2. BLOOD TYPING REAGENTS
  • 5.5. BLOOD SCREENING
    • 5.5.1. BLOOD SCREENING SYSTEMS
    • 5.5.2. BLOOD SCREENING REAGENTS
  • 5.6. BLOOD PROCESSING EQUIPMENT
    • 5.6.1. BLOOD PROCESSING EQUIPMENT SYSTEMS
    • 5.6.2. BLOOD PROCESSING EQUIPMENT REAGENTS

6. MARKET BY END-USER

  • 6.1. BLOOD & BLOOD COMPONENT BANKS
  • 6.2. DIAGNOSTIC LABORATORIES
  • 6.3. AMBULATORY SURGICAL CENTERS
  • 6.4. HOSPITALS
  • 6.5. OTHER END-USERS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. UNITED KINGDOM
    • 7.2.2. GERMANY
    • 7.2.3. FRANCE
    • 7.2.4. ITALY
    • 7.2.5. RUSSIA
    • 7.2.6. BELGIUM
    • 7.2.7. POLAND
    • 7.2.8. REST OF EUROPE
  • 7.3. ASIA PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. JAPAN
    • 7.3.3. INDIA
    • 7.3.4. SOUTH KOREA
    • 7.3.5. INDONESIA
    • 7.3.6. THAILAND
    • 7.3.7. VIETNAM
    • 7.3.8. AUSTRALIA & NEW ZEALAND
    • 7.3.9. REST OF ASIA PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILES

  • 8.1. ABBOTT LABORATORIES
  • 8.2. BIO-RAD LABORATORIES INC
  • 8.3. CSL LIMITED (CSL BEHRING)
  • 8.4. F HOFFMANN-LA ROCHE LTD
  • 8.5. GRIFOLS INTERNATIONAL SA
  • 8.6. HAEMONETICS CORPORATION
  • 8.7. MERCK & CO INC
  • 8.8. NOVO NORDISK A/S
  • 8.9. BAXTER INTERNATIONAL INC
  • 8.10. BECTON DICKINSON AND COMPANY
  • 8.11. FRESENIUS KABI AG
  • 8.12. ORTHO CLINICAL DIAGNOSTICS
  • 8.13. TERUMO CORPORATION (TERUMO BCT INC)
  • 8.14. IMMUCOR INC
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.